发明名称 Pyrrolidine modulators of CCR5 chemokine receptor activity
摘要 Pyrrolidine compounds of Formula (I), (wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6a</SUP>, R<SUP>6b</SUP>, R<SUP>7 </SUP>and R<SUP>8 </SUP>are defined herein) are described. The compounds are modulators of CCR5 chemokine receptor activity. The compounds are useful, for example, in the prevention or treatment of infection by HIV and the treatment of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described
申请公布号 US7125887(B2) 申请公布日期 2006.10.24
申请号 US20030399084 申请日期 2003.07.17
申请人 MERCK & CO., INC. 发明人 HALE JEFFREY J.;CALDWELL CHARLES G.;KIM DOOSEOP;SHEN DONG-MING;MILLS SANDER G.;CHAPMAN KEVIN T.;CHEN LIYA;MACCOSS MALCOLM;GENTRY AMY;LYNCH CHRISTOPHER L.;CHENG, LEGAL REPRESENTATIVE YUAN
分类号 A61K31/44;C07D487/04;A61K31/4162;A61K31/454;A61K31/4545;A61P1/04;A61P3/10;A61P7/00;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P13/12;A61P17/00;A61P17/04;A61P17/06;A61P19/00;A61P19/02;A61P19/08;A61P21/00;A61P21/02;A61P21/04;A61P25/00;A61P29/00;A61P31/18;A61P33/10;A61P33/12;A61P33/14;A61P35/00;A61P35/02;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D221/02;C07D401/14;C07D403/14;C07D405/14;C07D471/04;C07D491/052;C07D495/04 主分类号 A61K31/44
代理机构 代理人
主权项
地址